Skip to main content
logo
Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
42.43
-2.63 (-5.84%)
At close: Oct 28, 2026, 4:00 PM EDT
42.30
-0.13 (-0.31%)
After-hours: Oct 28, 2026, 7:59 PM EDT

Boston Scientific Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Oct '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Market Capitalization
61,49163,25963,43893,257141,351144,663158,907149,209131,642123,406113,219100,67384,69177,31177,76571,91066,27355,44653,28063,31060,534
Market Cap Growth (YoY)
-58.96%-56.27%-60.08%-37.50%7.38%17.23%40.36%48.21%55.44%59.62%45.59%40.00%27.79%39.43%45.95%13.58%9.48%-10.25%-12.31%15.31%17.59%
Enterprise Value
73,57675,58673,254103,503152,357156,391170,123160,256140,646131,667122,133109,62493,28186,59886,81980,32574,86964,49962,63870,91068,049
Last Close Price
45.0643.6542.6862.7595.3597.63107.41100.8889.3283.8077.0168.4957.8152.8054.0950.0346.2738.7337.2744.2942.48

Price Ratios

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Oct '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
PE Ratio
17.9218.0617.2626.1648.7851.8363.4473.4371.0468.8361.9057.0153.9164.8690.3285.00103.2393.0364.4384.0861.52
Forward PE
12.8313.4312.4318.1128.7131.2836.4135.2533.0832.8032.1830.4426.7625.2526.9726.2124.5120.6720.3625.0123.73
PS Ratio
2.973.003.024.527.047.488.598.507.867.767.446.855.955.625.805.515.234.414.325.215.09
PB Ratio
2.612.512.523.575.786.127.026.655.985.895.494.994.344.044.213.973.773.143.093.783.64
P/TBV Ratio
---347.98------208.12----------
P/FCF Ratio
17.29-17.5026.8438.6437.8345.6049.5149.7757.2461.50-47.2645.5651.5360.1370.6599.9089.85-46.00
P/OCF Ratio
13.84-14.0121.4831.1831.2737.0939.1438.3242.0343.0240.6433.8432.8636.6040.5343.4346.3244.70-32.37
PEG Ratio
1.021.080.831.101.652.262.982.882.422.682.752.512.192.052.182.382.301.811.761.781.64

EV Ratios

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Oct '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
EV/Sales Ratio
3.553.593.495.027.598.089.209.138.408.288.027.456.556.306.486.165.905.135.085.835.72
EV/EBITDA Ratio
12.9613.1112.5818.8228.5430.8436.1735.3532.9532.4230.9529.3125.8324.7425.6624.4823.6320.6920.4923.3323.33
EV/EBIT Ratio
17.2317.4216.6125.2138.3742.0450.2149.4046.8846.5844.9443.4238.6337.2639.0737.6436.8332.4832.3436.5537.31
EV/FCF Ratio
20.62-20.2129.7941.6540.9048.8253.1753.1761.0766.34-52.0551.0357.5367.1679.82116.22105.63-51.71

Financial Efficiency

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Oct '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Debt / Equity Ratio
0.500.500.500.420.490.510.530.520.510.540.530.550.490.490.510.520.530.510.540.580.57
Debt / EBITDA Ratio
2.172.371.971.942.092.132.312.282.412.692.412.692.512.502.552.632.772.752.833.113.01
Debt / FCF Ratio
--3.483.173.273.153.453.894.255.225.94-5.345.486.277.839.9616.1015.73-7.24
Net Debt / Equity Ratio
0.480.480.480.370.410.460.510.490.490.420.390.430.450.440.490.490.480.490.530.560.46
Net Debt / EBITDA Ratio
2.092.102.081.741.872.122.442.422.532.162.032.322.412.382.672.682.662.762.963.082.61
Net Debt / FCF Ratio
--3.332.762.742.823.303.644.094.064.365.114.864.925.987.358.9715.4915.2710.085.78
Asset Turnover
-0.490.470.490.480.500.470.470.450.450.430.430.420.430.420.400.400.400.380.39
Inventory Turnover
--2.022.122.202.122.312.072.121.971.981.931.901.911.992.152.242.242.342.312.45
Quick Ratio
--0.560.980.900.770.650.680.460.850.950.940.630.670.560.650.760.620.560.510.87
Current Ratio
--1.241.901.621.511.371.451.081.481.611.671.321.421.291.401.521.451.311.191.48
Return on Equity (ROE)
9.22%14.12%21.18%11.14%13.05%14.10%12.10%10.45%9.03%6.32%9.96%10.43%10.74%5.90%7.04%3.18%4.31%6.12%2.64%2.30%
Return on Assets (ROA)
-6.96%6.09%6.03%6.23%5.77%5.89%5.10%4.78%5.42%4.83%4.46%4.50%4.56%4.46%4.08%3.95%4.01%3.73%3.74%
Return on Invested Capital (ROIC)
2.08%2.92%3.06%2.89%2.47%2.36%2.36%2.43%1.73%2.13%1.97%2.21%1.83%1.41%1.56%0.71%1.48%1.49%1.36%1.56%
Return on Capital Employed (ROCE)
--11.40%10.30%10.40%10.00%9.30%9.20%9.10%8.80%8.60%8.00%8.00%7.90%7.70%7.40%7.10%7.00%6.80%6.90%6.50%

Yields

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Oct '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Earnings Yield
5.58%5.54%5.79%3.82%2.05%1.93%1.58%1.36%1.41%1.45%1.62%1.76%1.88%1.59%1.17%1.25%1.05%1.18%1.66%1.28%1.72%
FCF Yield
5.78%-5.71%3.73%2.59%2.64%2.19%2.02%2.01%1.75%1.63%1.69%2.12%2.20%1.94%1.66%1.42%1.00%1.11%1.47%2.17%
Payout Ratio
--------------5.18%4.46%9.29%7.45%5.38%12.73%13.68%
Buyback Yield / Dilution
0.91%2.91%1.25%-0.13%-0.38%-0.55%-0.63%-0.77%-0.90%-0.84%-1.92%-2.47%-2.39%-2.43%-1.28%-0.53%-0.43%-0.31%-0.37%-0.53%0.30%
SEC Filings: 10-K · 10-Q